PARIS--(BUSINESS WIRE)--Regulatory News:
At its meeting of 19 November 2013, the Board of Directors of Rémy Cointreau (Paris:RCO) decided, in accordance with the 11th and 13th resolutions approved by the general meeting of shareholders on 24 September 2013, to authorise the company’s Chief Executive Officer to implement a share buyback programme. Pursuant to this authorisation, a mandate was granted to an investment services provider to purchase shares in Rémy Cointreau SA up to a maximum of 2,500,000 shares.
The shares thus acquired will be used for cancellation purposes, in accordance with the description of the share buyback programme published in Rémy Cointreau’s Registration Document which was filed with the French Financial Markets Authority (Autorité des Marchés Financiers) on 12 July 2013 under the reference D.13-0737.
The investment services provider may purchase, on the dates it deems appropriate, up to a maximum of 2,500,000 shares under pricing conditions that comply with European (Commission) Regulation 2273/2003 dated 22 December 2003 and AMF General Regulations.
This buyback programme will end at the latest on 23 March 2015.
Rémy Cointreau reserves the right to stop the buyback programme.
This decision does not affect the performance of the liquidity contract signed by the company.
The description of the buyback programme (pages 155 of the Registration Document 2012/13), as well as the press release in relation to the decision of the general meeting of the shareholders dated 24 September 2013, are available on the website of the Company www.remy-cointreau.com – in the section "Financial Information".
This news release does not constitute a solicitation or an offer to buy Rémy Cointreau shares. If you wish to obtain more comprehensive information about Rémy Cointreau, please refer to the public documents registered in France with the Autorité des Marchés Financiers also available in English on our website www.remy-cointreau.com.
This news release may contain some forward-looking statements. Although Rémy Cointreau considers that these statements are based on reasonable hypotheses at the date of publication of this release, they are by their nature subject to risks and uncertainties which could cause actual results to differ materially from those indicated or projected in these statements.